Implantable Cardioverter-Defibrillators (ICD)

arrhythmias and the prevention of sudden death: a report of the American College of Cardiology Foundation, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 72:e91–e220, 2018 doi: 10.1016/j.jacc.2017.10.054, Towbin JA, McKenna WJ, Abrams DJ, et al: 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm 16:e301–e372, 2019, and Ommen SR, Ho CY, Asif IM, et al: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation 150(8):e198, 2024. doi: 10.1161/CIR.0000000000001277]. Circulation 149(23):e1239–e1311, 2024. doi:10.1161/CIR.0000000000001250 ICD malfunction ICDs may malfunction by Delivering inappropriate pacing or shocks Not delivering pacing or shocks when needed 7/8 ICDs may deliver inappropriate pacing or shocks in response to sinus rhythm, supraventricular tachycardia, atrial fibrillation, atrial flutter, or nonphysiologically generated impulses (eg. due to lead fracture). ICDs may not deliver appropriate pacing or shocks when needed because of factors such as lead or impulse generator migration, undersensing, an increase in pacing threshold due to fibrosis at the site of prior shocks, and battery depletion. When an ICD discharges For
